We are live on ! Find out more
ACA

Aptus Capital Advisors Portfolio holdings

AUM $12.7B
1-Year Est. Return 17.41%
This Fund
S&P 500
This Quarter Est. Return
+2.49%
1 Year Est. Return
+17.41%
3 Year Est. Return
+53.41%
5 Year Est. Return
+57.81%
10 Year Est. Return
AUM
$5.68B
AUM Growth
+$304M
Cap. Flow
+$187M
Cap. Flow %
3.29%
Top 10 Hldgs %
28.5%
Holding
1,247
New
80
Increased
530
Reduced
355
Closed
84

Sector Composition

Rank Sector Weight
1 Technology 11.47%
2 Financials 5.17%
3 Healthcare 4.4%
4 Consumer Discretionary 4.2%
5 Industrials 4.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IXP icon
1001
iShares Global Comm Services ETF
IXP
$520M
$14.3K ﹤0.01%
161
FVC icon
1002
First Trust Dorsey Wright Dynamic Focus 5 ETF
FVC
$105M
$14.1K ﹤0.01%
400
ACWX icon
1003
iShares MSCI ACWI ex US ETF
ACWX
$11.5B
$14.1K ﹤0.01%
265
+11
+4% +$587
URA icon
1004
Global X Uranium ETF
URA
$5.51B
$14K ﹤0.01%
+485
New +$14.8K
VWOB icon
1005
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.15B
$14K ﹤0.01%
223
-76
-25% -$4.8K
FGD icon
1006
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.55B
$13.8K ﹤0.01%
616
EFAD icon
1007
ProShares MSCI EAFE Dividend Growers ETF
EFAD
$63.3M
$13.5K ﹤0.01%
358
-60
-14% -$2.29K
LIT icon
1008
Global X Lithium & Battery Tech ETF
LIT
$1.53B
$13.4K ﹤0.01%
346
VTWV icon
1009
Vanguard Russell 2000 Value ETF
VTWV
$1.29B
$13.4K ﹤0.01%
100
SIL icon
1010
Global X Silver Miners ETF NEW
SIL
$4.11B
$13.2K ﹤0.01%
422
-160
-27% -$5.15K
SMMD icon
1011
iShares Russell 2500 ETF
SMMD
$3.56B
$12.5K ﹤0.01%
200
ARKG icon
1012
ARK Genomic Revolution ETF
ARKG
$1.6B
$12.2K ﹤0.01%
520
ESGV icon
1013
Vanguard ESG US Stock ETF
ESGV
$13.1B
$12K ﹤0.01%
124
SIZE icon
1014
iShares MSCI USA Size Factor ETF
SIZE
$430M
$12K ﹤0.01%
87
GOVI icon
1015
Invesco Equal Weight 0-30 Year Treasury ETF
GOVI
$1.22B
$11.8K ﹤0.01%
427
-405
-49% -$11.1K
PFFV icon
1016
Global X Variable Rate Preferred ETF
PFFV
$305M
$11.4K ﹤0.01%
484
DFSU
1017
Dimensional US Sustainability Core 1 ETF
DFSU
$2.26B
$11.4K ﹤0.01%
326
DON icon
1018
WisdomTree US MidCap Dividend Fund
DON
$4.04B
$10.9K ﹤0.01%
232
BOTZ icon
1019
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.25B
$10.7K ﹤0.01%
347
+201
+138% +$6.2K
PICK icon
1020
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.24B
$10.6K ﹤0.01%
260
DFSV
1021
Dimensional US Small Cap Value ETF
DFSV
$8.19B
$10.6K ﹤0.01%
368
PCY icon
1022
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
$10.6K ﹤0.01%
529
-150
-22% -$3.03K
SCMB icon
1023
Schwab Municipal Bond ETF
SCMB
$3.98B
$10.5K ﹤0.01%
410
CFA icon
1024
VictoryShares US 500 Volatility Wtd ETF
CFA
$539M
$10.4K ﹤0.01%
131
PKW icon
1025
Invesco BuyBack Achievers ETF
PKW
$1.72B
$10.4K ﹤0.01%
100

Similar funds

Aptus Capital Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Aptus Capital Advisors held 1,247 positions worth $5.68B, up 5.7% from $5.38B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Aptus Capital Advisors deployed $187M of net new capital in Q2 2024, opening 80 new positions and adding to 530 existing holdings. Its largest new stake was iShares US Pharmaceuticals ETF: 183,435 shares worth $12.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $18.1M trimmed.

  • Aptus Capital Advisors's largest Q2 2024 buy was iShares US Pharmaceuticals ETF: 183,435 shares worth $12.2M.
  • Aptus Capital Advisors added most to Invesco NASDAQ 100 ETF in Q2 2024, an estimated $27.6M increase.
  • Aptus Capital Advisors's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $18.1M.
  • Aptus Capital Advisors fully exited Crocs in Q2 2024, selling an estimated $4.27M.
  • Aptus Capital Advisors's ten largest holdings make up 29% of its $5.68B portfolio in Q2 2024.
  • Aptus Capital Advisors opened 80 new positions and closed 84 in Q2 2024.
  • Aptus Capital Advisors's portfolio value rose 5.7% quarter-over-quarter to $5.68B.

Based on Aptus Capital Advisors's 13F filing for Q2 2024, filed 31 Jul 2024.